Invasive Coronary Angiography Early in Ischemic Heart Failure
ICE-HF
1 other identifier
observational
2,994
1 country
1
Brief Summary
To compare the outcomes of patients with acute heart failure who undergo early coronary angiography vs. usual care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2015
CompletedFirst Submitted
Initial submission to the registry
January 27, 2020
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedAugust 29, 2022
August 1, 2022
5 years
January 27, 2020
August 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
All-cause mortality
Death from any cause after 14 days in landmark analysis
2 years
Cardiovascular mortality
Death due to cardiovascular causes after 14 days in landmark analysis
2 years
Secondary Outcomes (4)
All-cause hospital readmission
2 years
Heart failure readmission
2 years
Readmission for myocardial infarction
2 years
Rates of revascularization
90 days
Study Arms (2)
Early angiography
Patients admitted to hospital with acute heart failure undergoing coronary angiography within 14 days of hospital admission
Control
Patients admitted to hospital with acute heart failure not undergoing coronary angiography within 14 days
Interventions
Coronary angiogram performed either in hospital or post-discharge, within 14 days after initial hospital presentation with heart failure
Eligibility Criteria
Hospitalized patients in Ontario, Canada with acute heart failure
You may not qualify if:
- Recent myocardial infarction
- Coronary angiogram or revascularization within previous 3 months before admission
- Nonresidents of Ontario, invalid health card number
- HF diagnosed after admission
- Admission BNP or NT-proBNP not diagnostic of HF
- Died within 14 days of admission
- Palliative within 6 months prior to hospital admission
- Elevated creatinine concentration
- Documented anaphylactic contrast allergy
- Ischemic or hemorrhagic stroke within 3 months prior to admission
- Highest category of Hospital Frailty Risk Score
- Active severe bleeding at time of hospital admission
- Absolute platelet count \< 20
- Metastatic cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Health Network
Toronto, Ontario, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Douglas Lee, MD, PhD
ICES
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 27, 2020
First Posted
January 29, 2020
Study Start
April 1, 2010
Primary Completion
March 31, 2015
Study Completion
September 30, 2021
Last Updated
August 29, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share